Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

"Seems to me to be minimizing B OM because of lack of breakthrough and lack of partner. Understandable. Or we could just be haggling over true value of B OM. I'm sure the partner wants low risk and best deal. Same as us."

I had thought that for a while, but both ipix and Galera completed their 2b b-om trials within close proximity. Galera is a year into ph 3 b-om study, with another year to go.

Why the lengthy delay to start by ipix if all are to believe the tremendous benefits announced by the ceo and cso? Why?

Short answer, imo, understaffed, overpaid, mis-management, and underwhelming interest by both the investment community, the medical community, and business community. Why?

A one armed paper hanger gets little done.